Our Company

1-10 of 30

How is the English NHS prescription drugs budget spent?21 May 2019 - By Joanne Buckle and Tanya Hayward and Ankush Aggarwal and Lalima Chakravarty - Article

This paper provides a snapshot of the general practitioner prescription cost and activity as well as driving trends for financial year (FY) 2016/17 and FY 2017/18 in England.

Role of data in transforming UK private medical insurance analytics25 March 2019 - By Joanne Buckle and Natasha Singhal - Article

As insurers and providers delve into advanced analytics, each hopes to achieve more precise decisions for applications ranging from risk and finance to making individual patient care decisions.

Factors to consider for claims ratio projections of a private medical insurance business25 March 2019 - By Joanne Buckle and Ankush Aggarwal - Article

This article focusses on claims ratio projections in the context of the Indian health insurance market.

Analysis of insurers’ Solvency and Financial Condition Reports07 February 2019 - By Joanne Buckle and Tanya Hayward and Kevin Manning and Judith Houtepen and Ankush Aggarwal and Kishan Desai - Article

This analysis compares information provided in the Quantitative Reporting Templates and the Solvency and Financial Condition Reports and draws conclusions about the balance sheets and risk exposures of European health insurers.

Brief study of UK health insurers' second SFCRs31 January 2019 - By Joanne Buckle and Kevin Manning and Tanya Hayward and Ankush Aggarwal and Kishan Desai - Article

This analysis compares information provided in the Quantitative Reporting Templates and Solvency and Financial Condition Reports and draws conclusions about the balance sheets and risk exposures of 15 UK private medical insurance and health cash plan providers.

IFRS 17: Considerations for health insurers23 January 2019 - By Joanne Buckle and Neha Taneja - Article

While IFRS 17 aims to bring increased transparency in the financial reporting by insurers, the complexities related to some aspects of it need to be carefully considered for short-term health insurers when esimating the financial, operational and business impact within the organisation’s governance frameworks.

Care management impact model17 December 2018 - By Joanne Buckle and Tanya Hayward - Article

This unique model helps you quantify the impact of care management programmes and redirecting care within the system on overall healthcare resource utilisation.

Using the Milliman Advanced Risk Adjusters (MARA) tool in the UK PMI market10 December 2018 - By Joanne Buckle and Tanya Hayward and Kishan Desai - Article

Can a risk adjustment algorithm do an effective job in population risk stratification, given data and system challenges, such that there can be a better understanding of member risk profiles within the context of UK private medical insurance?

Actuarial cost projection model20 September 2018 - By Joanne Buckle and Tanya Hayward - Article

This paper provides an overview of Milliman’s actuarial population cost projection model, which creates standardised measures and projections of cost and utilisation using our proprietary Health Cost Guidelines.

Can we use insurance-based reimbursement models for novel antibiotics?05 September 2018 - By Joanne Buckle and Tanya Hayward - Article

The lack of financial incentives associated with developing novel antibiotics has resulted in limited innovation in this area, though it is needed.


  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman